In amnestic mild cognitive impairment (AMCI, a transition stage between normal aging and AD), brains examined postmortem were characterized by diminished Trx-1 levels in the hippocampus and cerebellum [112]. The gene discussed is TXN; the disease is Alzheimer disease.